Exchange: NASDAQ·Updated 07:33 PM EDT
CNTA logo

CNTACentessa Pharmaceuticals PLC - ADR

$40.50
$0.32
(0.80%)
Today
Closed $40.50
$0.1835
(0.45%)
After Hours
EarningsAug 11
Mkt Cap$6.27B
Vol11.33M

About

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of medicines that are transformational for patients. It is primarily focused on developing orexin receptor agonists for neurological and neurodegenerative disorders, including programs targeting narcolepsy, idiopathic hypersomnia, and other neuropsychiatric conditions, as well as its early-stage LockBody immuno-oncology platform. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
118

Frequently Asked Questions

What is Market Cap of Centessa Pharmaceuticals plc - ADR?
What is the 52-week high for Centessa Pharmaceuticals plc - ADR?
What is the 52-week low for Centessa Pharmaceuticals plc - ADR?
What is Centessa Pharmaceuticals plc - ADR stock price today?
What was Centessa Pharmaceuticals plc - ADR stock price yesterday?
What is the PE ratio of Centessa Pharmaceuticals plc - ADR?
What is the Price-to-Book ratio of Centessa Pharmaceuticals plc - ADR?
What is the 50-day moving average of Centessa Pharmaceuticals plc - ADR?
How many employees does Centessa Pharmaceuticals plc - ADR have?

Advertisement|Remove ads.